Myocardial Adenosine Receptors
Myocardial Adenosine Receptors
批准号:
7633118
负责人:
JAMES G DOBSON
金额:
$40.63万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-11 至 2011-06-30
关键词:
AdenosineAdenosine A1 ReceptorAdenosine A2A ReceptorAdenosine A3 ReceptorAdrenergic AntagonistsAdrenergic ReceptorAffectAttenuatedBindingBiochemicalCardiacCardiac MyocytesDevelopmentDoctor of PhilosophyEnsureEventFunctional disorderG-Protein-Coupled ReceptorsHeartIschemiaKnockout MiceKnowledgeLaboratoriesMechanicsMediatingMembraneMetabolicMitogen-Activated Protein KinasesModificationMolecularMuscle CellsMyocardialMyocardiumOperative Surgical ProceduresPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPlayProtein IsoformsProtein KinaseProtein Kinase CProtein phosphataseProteinsPurinergic P1 ReceptorsRattusReceptor SignalingRegulationReportingRoleSarcolemmaSignal PathwaySignal TransductionTissuesTranslatingVentriculardesignheart functionhuman MAPK14 proteinmyocardial hypoxiaprotein kinase C epsilonreceptorreceptors for activated C kinaseresponse
中文摘要
描述(由申请人提供):已知心肌中的腺苷受体在正常和患病心脏的心功能中起重要作用。该实验室先前的研究主要集中在这些受体刺激引起的细胞反应上。此外,研究已经开始调查受体信号如何在心脏中转化为细胞反应。然而,关于引发反应的机制细节和心脏腺苷受体之间的交叉调节知之甚少。我们和其他人报道了腺苷A1受体(A1R),腺苷A2A受体(A2AR)和?肾上腺素能受体(?1r)刺激可对心室肌细胞产生一系列影响。A1R具有重要的抗肾上腺素能作用,A2AR引起正性肌力反应。此外,A2AR一起减弱了A1 - r介导的抗肾上腺素能作用。然而,对于包括腺苷A3受体(A3R)在内的A1R和A2AR的信号转导机制和相互作用所涉及的分子事件知之甚少。因此,本项目的目的将是确定涉及蛋白激酶和磷酸酶在心脏中A1R-, A2AR-和a3r介导作用的分子信号转导机制。此外,这些腺苷受体在调节心脏机械和代谢功能中的作用将被确定。利用大鼠和A1R、A2AR和双(A1R+A2AR)敲除小鼠心室肌细胞、肌细胞膜和灌注心脏,拟开展的研究应揭示:1)A1R刺激是否导致蛋白激酶C异构体易位并结合心肌肌膜的RACK(受体活化C激酶)蛋白。此外,p38-MAPK(丝裂原活化蛋白激酶)在A1 - r介导的抗肾上腺素能作用中的作用也将被研究,2)A3R刺激引起的抗肾上腺素能作用的重要性以及PKC亚型是否参与,3)A2AR抑制A1R介导的心脏抗肾上腺素能作用的方式,4)蛋白磷酸酶在A1R、A2AR和A3R刺激产生的心脏作用中的作用和重要性。5)心肌缺氧和/或缺血如何改变a1r、A2AR和/或A3R的功能,从而增加或减少它们在调节心功能中的作用。这些研究结果将为心肌中腺苷受体的分子功能提供新的信息。此外,这一发现将显著有助于我们了解G蛋白偶联受体在正常和病变心脏中运作的分子机制。这些信息应该有助于开发新的治疗方法和药物来缓解心功能障碍。
英文摘要
DESCRIPTION (provided by applicant): Adenosine receptors in the myocardium are known to play an important role in cardiac function in both the normal and diseased heart. Prior studies in this laboratory have focused on the cellular responses elicited upon stimulation of these receptors. In addition studies have been initiated to investigate how the receptor signals are translated into cellular responses in the heart. However, little is known regarding the details of the mechanisms involved in the elicited responses and the cross-regulation between cardiac adenosine receptors. We and others have reported that adenosine A1 receptor (A1R), adenosine A2A receptor (A2AR) and ?1 adrenergic receptor (?1 R) stimulation results in a number of effects in ventricular myocytes. The A1R serves an important antiadrenergic action, and the A2AR causes a positive inotropic response. Furthermore, together, the A2AR attenuates the A1 R-mediated antiadrenergic actions. However, little is known about the molecular events involved in adenosine receptor signal transduction mechanisms and interaction of the A1R and A2AR including the adenosine A3 receptor (A3R). Thus, the objective of this project will be to determine the molecular signal transduction mechanisms involving protein kinases and phosphatases in the A1R-, A2AR- and A3R-mediated actions in the heart. In addition the operation of these adenosine receptors in regulating cardiac mechanical and metabolic function will be determined. Using rat and A1 R, A2AR and double (A1R+A2AR) knockout mice ventricular myocytes, myocyte membranes and perfused hearts, the proposed studies should reveal: 1) Whether A1R stimulation causes protein kinase C isoforms to translocate and bind to RACK (receptor activated C kinase) proteins of the myocardial sarcolemma. Also the involvement of p38-MAPK (mitogen activated protein kinase) in the A1 R-mediated antiadrenergic action will be investigated, 2) The importance of the antiadrenergic action resulting from A3R stimulation and whether PKC isoforms are involved, 3) The way in which A2AR inhibits A1R mediated cardiac antiadrenergic actions, 4) The effect and importance of protein phosphatases in the cardiac effects produced by A1R, A2AR and A3R stimulation, and 5) How myocardial hypoxia and/or ischemia modifies the function of A1 R, A2AR and/or A3R, thereby increasing or reducing their roles in modulating heart function. The results obtained from these studies will provide new information regarding the molecular functioning of adenosine receptors in the myocardium. Additionally, the findings should significantly contribute to our knowledge of the molecular mechanisms of G- protein coupled receptor operation in the normal and diseased heart. Such information should be instrumental for the development of new therapies and agents to alleviate cardiac dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myocardial Adenosine Receptors
-
批准号:7842055
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2009
-
负责人:JAMES G DOBSON
-
依托单位:
Myocardial Adenosine Receptors
-
批准号:7304627
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2007
-
负责人:JAMES G DOBSON
-
依托单位:
Myocardial Adenosine Receptors
-
批准号:7868038
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2007
-
负责人:JAMES G DOBSON
-
依托单位:
Myocardial Adenosine Receptors
-
批准号:7467409
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2007
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISM OF AGING-ENHANCED HEART ADENOSINE
-
批准号:6717663
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISM OF AGING-ENHANCED HEART ADENOSINE
-
批准号:6509587
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE A1 AND A2 RECEPTORS IN THE MYOCARDIUM
-
批准号:6499100
-
项目类别:
-
资助金额:$35.59万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISM OF AGING-ENHANCED HEART ADENOSINE
-
批准号:6094566
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE A1 AND A2 RECEPTORS IN THE MYOCARDIUM
-
批准号:6225862
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISM OF AGING-ENHANCED HEART ADENOSINE
-
批准号:6629794
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE A1 AND A2 RECEPTORS IN THE MYOCARDIUM
-
批准号:6700869
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE A1 AND A2 RECEPTORS IN THE MYOCARDIUM
-
批准号:6629098
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2001
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISMS OF AGING--ENHANCED HEART ADENOSINE
-
批准号:3123415
-
项目类别:
-
资助金额:$17.48万
-
财政年份:1993
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISMS OF AGING--ENHANCED HEART ADENOSINE
-
批准号:2413322
-
项目类别:
-
资助金额:$21.18万
-
财政年份:1993
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISMS OF AGING--ENHANCED HEART ADENOSINE
-
批准号:2052679
-
项目类别:
-
资助金额:$19.59万
-
财政年份:1993
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISMS OF AGING--ENHANCED HEART ADENOSINE
-
批准号:2052678
-
项目类别:
-
资助金额:$18.9万
-
财政年份:1993
-
负责人:JAMES G DOBSON
-
依托单位:
MECHANISMS OF AGING--ENHANCED HEART ADENOSINE
-
批准号:2052680
-
项目类别:
-
资助金额:$20.37万
-
财政年份:1993
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE AND BETA-ADRENERGIC ACTION IN THE AGING HEART
-
批准号:3352380
-
项目类别:
-
资助金额:$18.27万
-
财政年份:1986
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE AND BETA-ADRENERGIC ACTION IN THE AGING HEART
-
批准号:3352387
-
项目类别:
-
资助金额:$17.42万
-
财政年份:1986
-
负责人:JAMES G DOBSON
-
依托单位:
ADENOSINE AND BETA-ADRENERGIC ACTION IN THE AGING HEART
-
批准号:3352385
-
项目类别:
-
资助金额:$17.57万
-
财政年份:1986
-
负责人:JAMES G DOBSON
-
依托单位:
海外基金